3Q2016 Hedge Fund Activity Related to AMP Portfolio companies


As the third quarter of 2016 has ended, 13F forms from institutional investors are now becoming available. The 13F form is filed with the SEC and discloses all trades for institutions (e.g. hedge funds) managing >$100M. We list out below, trades that were made last quarter by biotech hedge funds we follow, of shares of companies within our AMP Biopharma Fantasy Portfolio:

ALKS:

  • OrbiMed Advisors LLC sold 100% of their position totaling 172K shares

  • Iguana Healthcare Mgmt sold 100% of their position totaling 30K shares

FGEN:

  • EcoR1 Capital LLC sold 13% of their position totaling 103K shares

  • Nexthera Capital LP sold 17% of their position totaling 26K shares

NKTR:

  • RA Capital Mgmt LLC increased their position 13% adding 439K shares

  • Cormorant Asset Mgmt LLC sold 100% of their position totaling 2M shares

OPHT:

  • Perceptive Advisors LLC initiated a new position (Call) for 600K shares

  • Redmile Group LLC initiated a new position for 505K shares

  • Dafna Capital Mgmt LLC initiated a new position for 47K shares

  • Iguana Healthcare Mgmt initiated a new position for 35K shares

  • Nexthera Capital LP initiated a new position for 24K shares

  • OrbiMed Advisors LLC sold 45% of their position totaling 982K shares

QURE:

  • OrbiMed Advisor LLC added to their position 294K shares

  • Dafna Capital Mgmt LLC increased their position 28% adding 45K shares

  • Nexthera Capital LP sold 100% of their position totaling 93K shares

  • Perceptive Advisors LLC sold 2% of their position totaling 29K shares

CYTR:

  • OrbiMed Advisor LLC added to their position 294K shares

  • Dafna Capital Mgmt LLC increased their position 28% adding 45K shares

  • Nexthera Capital LP sold 100% of their position totaling 93K shares

  • Perceptive Advisors LLC sold 2% of their position totaling 29K shares

Some common buys among institutions analyzed:

BOLD – OrbiMed, RA, Redmile, Cormorant, Foresite, Perceptive

OPHT – Perceptive, Redmile, Dafna, Iguana, Nexthera

ARDX – RA, Cormorant, EcoR1, Perceptive

ARRY – OrbiMed, Cormorant, Iguana, Dafna

OMED – BVF, EcoR1, Iguana,

Some common sells among institutions analyzed:

NVAX – Baker Bros, Cormorant, Dafna, Iguana, Perceptive

ARRY – Redmile, BVF, Baker Bros, Nexthera, EcoR1

CYTK – EcoR1, Iguana

RTRX – EcoR1, Perceptive

EPZM – EcoR1, Iguana

Biotech Hedgefunds Included

Perceptive Advisors LLC

EcoR1 Capital LLC

RA Capital Mgmt LLC

BVF Inc

Dafna Capital Mgmt LLC

Baker Bros Advisors LP

Redmile Group LLC

Cormorant Asset Mgmt LLC

Foresite Capital Mgmt LLC

OrbiMed Advisors LLC

Iguana Healthcare Mgmt LLC

Nexthera Capital LP

Palo Alto Investors LLC


*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon